BioGaia publishes annual report for 2021

Today, BioGaia AB (publ) publishes its Annual Report, Remuneration Report and Sustainability Report for the financial year 2021. In line with BioGaia’s sustainability strategy the reports will not be printed but are only held available at BioGaia’s website www.biogaia.com under the section Investors – Reports and presentations/Annual reports. 

Latest press releases from BioGaia
04.02.2022 BioGaia AB – Year-end Report 2021
03.02.2022 BioGaia’s probiotic reduces inflammation in patients with diverticulitis
30.12.2021 BioGaia acquires it’s US distributor - strengthening its market position in the US

This disclosure contains information that BioGaia is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 28-03-2022 08:00 CET.

For additional information please contact
Isabelle Ducellier, CEO

Phone: +46(0)85 552 93 00

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in more than 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com